Background Multiple sclerosis (MS) is a chronic, demyelinating disease of the central
nervous system that results in progressive and irreversible disability. Fatigue is one of the …

Worldwide, over 2.2 million people suffer from multiple sclerosis (MS), a multifactorial
demyelinating disease of the central nervous system. MS is characterized by a wide range of …

Novel, neuroprotective uses of Copaxone (generic name: glatiramer acetate—GA) are being
examined, primarily in neurological conditions involving cognitive decline. GA is a well …

Depression and anxiety are the most frequent neuropsychiatric symptoms of multiple
sclerosis (MS), an autoimmune-mediated demyelinating neurodegenerative disease. Their …

Introduction: The chronic nature of Multiple Sclerosis (MS), have can leave devastating
effects on quality of life and fatigue. The present research aimed to study the effect of group …

BACKGROUND: Performance and perceived satisfaction of daily occupations in people with
multiple sclerosis (MS) can affect the perception of their quality of life and be impacted by the …

Next to the disseminated clinical symptoms, cognitive dysfunctions are common features of
multiple sclerosis (MS). Over the recent years several different MRI measures became …

Objectives To determine the mediating effects of depression on health-related quality of life
and fatigue in individuals with multiple sclerosis (MS). Design A cross-sectional study …

More than 700,000 people suffer from multiple sclerosis (MS) in Europe. This implies that
more than 1 million people are affected by this disease through their role as caregivers and …

Background Persons with multiple sclerosis (PwMS) commonly experience cognitive fatigue
(CF), defined as a decrease in cognitive performance with sustained activity, yet CF remains …